An S101P Substitution in the Putative Cleavage Motif of the Human Metapneumovirus Fusion Protein Is a Major Determinant for Trypsin-Independent Growth in Vero Cells and Does Not Alter Tissue Tropism in Hamsters
Open Access
- 15 August 2005
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (16) , 10678-10689
- https://doi.org/10.1128/jvi.79.16.10678-10689.2005
Abstract
Human metapneumovirus (hMPV), a recently described paramyxovirus, is a major etiological agent for lower respiratory tract disease in young children that can manifest with severe cough, bronchiolitis, and pneumonia. The hMPV fusion glycoprotein (F) shares conserved functional domains with other paramyxovirus F proteins that are important for virus entry and spread. For other paramyxovirus F proteins, cleavage of a precursor protein (F0) into F1 and F2 exposes a fusion peptide at the N terminus of the F1 fragment, a likely prerequisite for fusion activity. Many hMPV strains have been reported to require trypsin for growth in tissue culture. The majority of these strains contain RQSR at the putative cleavage site. However, strains hMPV/NL/1/00 and hMPV/NL/1/99 expanded in our laboratory contain the sequence RQPR and do not require trypsin for growth in Vero cells. The contribution of this single amino acid change was verified directly by generating recombinant virus (rhMPV/NL/1/00) with either proline or serine at position 101 in F. These results suggested that cleavage of F protein in Vero cells could be achieved by trypsin or S101P amino acid substitution in the putative cleavage site motif. Moreover, trypsin-independent cleavage of hMPV F containing 101P was enhanced by the amino acid substitution E93K. In hamsters, rhMPV/93K/101S and rhMPV/93K/101P grew to equivalent titers in the respiratory tract and replication was restricted to respiratory tissues. The ability of these hMPV strains to replicate efficiently in the absence of trypsin should greatly facilitate the generation, preclinical testing, and manufacturing of attenuated hMPV vaccine candidates.Keywords
This publication has 80 references indexed in Scilit:
- Analysis of Replication Kinetics of the Human Metapneumovirus in Different Cell Lines by Real-Time PCRJournal of Clinical Microbiology, 2005
- A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeysVaccine, 2004
- Recovery of Human Metapneumovirus Genetic Lineages A and B from Cloned cDNAJournal of Virology, 2004
- The Two Major Human Metapneumovirus Genetic Lineages Are Highly Related Antigenically, and the Fusion (F) Protein Is a Major Contributor to This Antigenic RelatednessJournal of Virology, 2004
- Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine designJournal of General Virology, 2004
- Subgroup C avian metapneumovirus (MPV) and the recently isolated human MPV exhibit a common organization but have extensive sequence divergence in their putative SH and G genesJournal of General Virology, 2003
- Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicityArchiv für die gesamte Virusforschung, 1993
- Post-translational Processing and Oligomerization of the Fusion Glycoprotein of Human Respiratory Syncytial VirusJournal of General Virology, 1991
- Mammalian subtilisins: The long-sought dibasic processing endoproteasesCell, 1991
- Viral and Cellular Membrane Fusion ProteinsAnnual Review of Physiology, 1990